CompletedNot applicableNCT01785407

Using Stable Iron Isotopic Techniques and Serum Hepcidin Profiles to Optimize Iron Supplementation

Studying Autosomal recessive sideroblastic anemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Swiss Federal Institute of Technology
Principal Investigator
Diego Moretti, PhD
ETH Zürich
Intervention
Iron Supplement (Ferrous Sulfate Dried)(dietary_supplement)
Enrollment
25 enrolled
Eligibility
18-45 years · FEMALE
Timeline
20132013

Study locations (1)

Collaborators

ETH Zürich · University Hospital, Zürich

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01785407 on ClinicalTrials.gov

Other trials for Autosomal recessive sideroblastic anemia

Additional recruiting or active studies for the same condition.

See all trials for Autosomal recessive sideroblastic anemia

← Back to all trials